MM
Mayank Mamtani B. Riley Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Healthcare
Communication Services
Entertainment
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $30 |
63%
upside
| 1 | +8.7% |
0
%
| 10 Oct ‘25 10 days ago |
|
|
|
Buy
Reiterated
| $74 |
85%
upside
| 2 | +20% |
0
%
| 1 Oct ‘25 18 days ago |
|
|
|
Buy
Maintained
| $560 |
28%
upside
| 1 | +16% |
0
%
| 29 Sep ‘25 20 days ago |
|
|
|
Buy
Maintained
| $105 |
82%
upside
| 1 | +60% |
0
%
| 23 Sep ‘25 26 days ago |
|
|
|
Buy
Maintained
| $80 |
37%
upside
| 1 | +20% |
0
%
| 22 Sep ‘25 27 days ago |
|
|
|
Buy
Maintained
| $55 |
59%
upside
| 1 | +8.4% |
0
%
| 17 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $28 |
96%
upside
| 1 | +4.1% |
0
%
| 12 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $20 |
167%
upside
| 1 | -6.3% |
0
%
| 26 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $18 |
370%
upside
| 1 | +5.8% |
0
%
| 13 Aug ‘25 2 months ago |
|